New Study Identifies Connection Between Diabetes Medications, Multiple Sclerosis

Researchers at the Center for Innovation in Brain Science examined the impact of medication exposure in people with Type 2 diabetes on the risk of developing multiple sclerosis.

The study found that anti-hyperglycemic medications used to treat Type 2 diabetes resulted in an increased risk of multiple sclerosis for people older than 45, particularly among women.Continue reading

AZ FAST Grants – Apply by Dec 31 2022

FEDERAL AND STATE TECHNOLOGY (FAST) PARTNERSHIP PROGRAM

The Arizona Commerce Authority has partnered with the Small Business Administration to facilitate the SBIR program in Arizona. Arizona’s FAST program provides funds, resources, training, and network opportunities to help entrepreneurs succeed in their SBIR proposal.

Please note: FAST Grant funding is only available to Arizona businesses seeking an SBIR-funded grant. FAST Grant applications are being accepted through December 31, 2022.

 

  LEARN MORE  

 

 

 

CashLabs LLC Acquires Beacon Biomedical Inc.

Phoenix, Ariz. (November 1, 2022) – CashLabs LLC, a Tucson Arizona based national laboratory platform, announced the acquisition of Beacon Biomedical, a Phoenix Arizona based CLIA accredited medical laboratory focused on the development and commercialization of early detection cancer screening tests.Continue reading

BIO and AZBio 2022 Reports Illustrate Bioindustry Impact

The Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) today released new data on the bioscience industry in the United States. The report includes individual fact sheets for all 50 states, the District of Columbia and Puerto Rico, which can be found alongside the full report and interactive map at www.bio.org/jobs.  AZBio uses this data and additional federally reported data to build its statewide progress report.

Continue reading

NeoLight acquires first-of-its-kind musical pacifier technology for premature babies

SCOTTSDALE, Ariz., Oct. 25, 2022 /PRNewswire/ — NeoLight has signed an agreement to acquire the Pacifier Activated Lullaby (PAL®) System by Powers Medical Inc., a US-based medical technology company that focuses on musical therapy in the newborn baby market. This acquisition strengthens the NeoLight neonatal portfolio by introducing a solution for two growing concerns in newborn care; Non-nutritive sucking (NNS) and Neonatal Abstinence Syndrome (drug-addicted babies).Continue reading